28344199|t|Association of Toll-Like Receptor 4 on Human Monocyte Subsets and Vulnerability Characteristics of Coronary Plaque as Assessed by 64-Slice Multidetector Computed Tomography
28344199|a|Although Toll-like receptor 4 (TLR-4) is involved in monocyte activation in patients with accelerated forms of atherosclerosis, the relationship between the expression of TLR-4 on circulating monocyte s and coronary plaque vulnerability has not previously been evaluated. We investigated this relationship using 64-slice multidetector computed tomography (MDCT) in patients with stable angina pectoris (SAP).Methods and Results:We enrolled 65 patients with SAP who underwent MDCT. Three monocyte subsets (CD14(++)CD16(-), CD14(++)CD16(+), and CD14(+)CD16(+)) and expression of TLR-4 were measured by flow cytometry. Intracoronary plaques were assessed by 64-slice MDCT. We defined vulnerability of intracoronary plaques according to the presence of positive remodeling (remodeling index >1.05) and/or low CT attenuation (<35 HU). The circulating CD14(++)CD16(+)monocytes more frequently expressed TLR-4 than CD14(++)CD16(-) and CD14(+)CD16(+)monocytes (P<0.001). The relative proportion of the expression of TLR-4 on CD14(++)CD16(+)monocytes was significantly greater in patients with vulnerable plaque compared with those without (10.4 [4.1-14.5] % vs. 4.5 [2.8-7.8] %, P=0.012). In addition, the relative proportion of TLR-4 expression on CD14(++)CD16(+)monocytes positively correlated with the remodeling index (r=0.28, P=0.025) and negatively correlated with CT attenuation value (r=-0.31, P=0.013). Upregulation of TLR-4 on CD14(++)CD16(+)monocytes might be associated with coronary plaque vulnerability in patients with SAP.
28344199	0	11	Association	T080	C0439849
28344199	15	35	Toll-Like Receptor 4	T116,T192	C1411976
28344199	39	44	Human	T016	C0086418
28344199	45	53	Monocyte	T025	C0026473
28344199	54	61	Subsets	T185	C1515021
28344199	66	79	Vulnerability	T033	C1821973
28344199	80	95	Characteristics	T080	C1521970
28344199	99	107	Coronary	T023	C0018787
28344199	108	114	Plaque	T033	C0332461
28344199	118	126	Assessed	T052	C1516048
28344199	130	172	64-Slice Multidetector Computed Tomography	T060	C3179130
28344199	182	202	Toll-like receptor 4	T116,T192	C1411976
28344199	204	209	TLR-4	T116,T192	C1411976
28344199	226	245	monocyte activation	T043	C1155075
28344199	249	257	patients	T101	C0030705
28344199	263	274	accelerated	T169	C0521110
28344199	284	299	atherosclerosis	T047	C0004153
28344199	305	317	relationship	T080	C0439849
28344199	330	340	expression	T045	C0597360
28344199	344	349	TLR-4	T116,T192	C1411976
28344199	353	364	circulating	T169	C0175630
28344199	365	373	monocyte	T025	C0026473
28344199	380	388	coronary	T023	C0018787
28344199	389	395	plaque	T033	C0332461
28344199	396	409	vulnerability	T033	C1821973
28344199	434	443	evaluated	T058	C0220825
28344199	466	478	relationship	T080	C0439849
28344199	485	527	64-slice multidetector computed tomography	T060	C3179130
28344199	529	533	MDCT	T060	C3179130
28344199	538	546	patients	T101	C0030705
28344199	552	574	stable angina pectoris	T047	C0340288
28344199	576	579	SAP	T047	C0340288
28344199	616	624	patients	T101	C0030705
28344199	630	633	SAP	T047	C0340288
28344199	648	652	MDCT	T060	C3179130
28344199	660	668	monocyte	T025	C0026473
28344199	669	676	subsets	T185	C1515021
28344199	678	693	CD14(++)CD16(-)	T025	C0026473
28344199	695	710	CD14(++)CD16(+)	T025	C0026473
28344199	716	730	CD14(+)CD16(+)	T025	C0026473
28344199	736	746	expression	T045	C0597360
28344199	750	755	TLR-4	T116,T192	C1411976
28344199	773	787	flow cytometry	T059	C0016263
28344199	789	802	Intracoronary	T023	C0018787
28344199	803	810	plaques	T033	C0332461
28344199	816	824	assessed	T052	C1516048
28344199	828	841	64-slice MDCT	T060	C3179130
28344199	854	867	vulnerability	T033	C1821973
28344199	871	884	intracoronary	T023	C0018787
28344199	885	892	plaques	T033	C0332461
28344199	922	941	positive remodeling	T046	C3854505
28344199	943	959	remodeling index	T033	C0243095
28344199	978	980	CT	T060	C0040405
28344199	981	992	attenuation	T081	C2986722
28344199	1007	1018	circulating	T169	C0175630
28344199	1019	1043	CD14(++)CD16(+)monocytes	T025	C0026473
28344199	1060	1069	expressed	T045	C0597360
28344199	1070	1075	TLR-4	T116,T192	C1411976
28344199	1081	1096	CD14(++)CD16(-)	T025	C0026473
28344199	1101	1124	CD14(+)CD16(+)monocytes	T025	C0026473
28344199	1167	1177	expression	T045	C0597360
28344199	1181	1186	TLR-4	T116,T192	C1411976
28344199	1190	1214	CD14(++)CD16(+)monocytes	T025	C0026473
28344199	1244	1252	patients	T101	C0030705
28344199	1258	1275	vulnerable plaque	T033	C0332461
28344199	1394	1399	TLR-4	T116,T192	C1411976
28344199	1400	1410	expression	T045	C0597360
28344199	1414	1438	CD14(++)CD16(+)monocytes	T025	C0026473
28344199	1450	1460	correlated	T080	C1707520
28344199	1470	1486	remodeling index	T033	C0243095
28344199	1520	1530	correlated	T080	C1707520
28344199	1536	1538	CT	T060	C0040405
28344199	1539	1556	attenuation value	T081	C2986722
28344199	1577	1589	Upregulation	T044	C0949479
28344199	1593	1598	TLR-4	T116,T192	C1411976
28344199	1602	1626	CD14(++)CD16(+)monocytes	T025	C0026473
28344199	1636	1651	associated with	T080	C0332281
28344199	1652	1660	coronary	T023	C0018787
28344199	1661	1667	plaque	T033	C0332461
28344199	1668	1681	vulnerability	T033	C1821973
28344199	1685	1693	patients	T101	C0030705
28344199	1699	1702	SAP	T047	C0340288